| 0539 | Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial | Dalziel SR, Liang A, Parag V, Rodgers A, Harding JE, Robinson JS; ACTORDS Study Group | New Zealand |
| 0540 | Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial | Dalziel SR, Walker NK, Parag V, et al., Harding JE, Robinson JS; ACTORDS Study Group | New Zealand |
| 0565 | Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial | Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, Harding JE | New Zealand |
| 0672 | Outcomes at 2 years of age after repeat doses of antenatal corticosteroids | Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS; ACTORDS Study Group, Harding JE | Australia |
| 0673 | Long-term outcomes after repeat doses of antenatal corticosteroids | Wapner RJ, Sorokin Y, Mele L, et al., Harding JE, Robinson JS; ACTORDS Study Group, Harding JE | USA |
| 0811 | Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial. | Dalziel SR, Rea HH, et al., McCarthy D, Parag V, Rodgers A, Harding JE | New Zealand |
| 0812 | Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial | Dalziel SR, Walker NK, et al., McCarthy D, Parag V, Rodgers A, Harding JE | New Zealand |
| 0869 | Prenatal glucocorticoid treatment and later mental health in children and adolescents. | Khalife N, Glover V, et al. | Finland |